Deep Track Capital, LP - Jun 30, 2025 SCHEDULE 13G/A Report for Maze Therapeutics Inc. Common Stock, $0.001 par value per share (MAZE)

Filing Manager
Deep Track Capital, LP
Reporting Manager
Deep Track Capital, LP
Security
Maze Therapeutics Inc. Common Stock, $0.001 par value per share
Symbol
MAZE
Shares outstanding
43.8M shares
Disclosed Ownership
3.95M shares
Ownership
9.02%
Form type
SCHEDULE 13G/A
Date filed
8/14/2025, 08:48 AM
Date of event
Jun 30, 2025
Previous filing
Feb 7, 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Deep Track Capital, LP 9.02% 3.95M 0 3.95M /s/ David Kroin David Kroin, Managing Member of the General Partner of the Investment Adviser
Deep Track Biotechnology Master Fund, Ltd. 9.02% 3.95M 0 3.95M /s/ David Kroin David Kroin, Director
David Kroin 9.02% 3.95M 0 3.95M /s/ David Kroin David Kroin